Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

What Do These Three Charts Have in Common?

Bob Moriarty of 321gold provides three charts for readers. Hint: That's what massive tops look like. Don't tell anyone else, I want to keep it a secret between you and me. Bob Moriarty founded 321gold.com , with his late wife, Barbara Moriarty, more...
Streetwise Reports | February 5, 2020 |

Gold Is Due a Correction

All markets go up. All markets go down. No market ever goes straight up unless it's the end of the world and in that case why would you care? Gold hit bottom in early 2016. Smart money was buying then. Gradually gold rose and fell with the tide until lately when it we...
Streetwise Reports | August 13, 2019 |

Q2 Earnings Beat Boosts Caleres Stock 24%, But Is There Room to Run in This Rally?

Investors responded favorably to this footwear stock's Q2/19 results, elevating the stock price 24% on Tuesday. However, the stock is still down quite a bit from its 6-month and 1-year highs. Footwear company Caleres Inc. (CAL:NYSE) reported an assortment of positiv...
Streetwise Reports | August 28, 2019 |

Energy Firm Reacts to Oil Price Weakening with 2019 Budget Decrease

The company's revised estimates, the reasons for and repercussions of them are addressed in a CIBC report. In an Aug. 26 research note, analyst Dave Popowich reported that his firm CIBC reduced its price target on Whitecap Resources Inc. (WCP:TSX) to CA$7.25 per sha...
Streetwise Reports | September 3, 2019 |

Silver, Gold and Platinum Are Due a Break

When you are climbing the steepest of mountains, especially at high altitudes, it can be tiring. If you start getting a nosebleed, you are simply working too hard and need a break. The DSI (Daily Sentiment Index) on gold hit 97 four weeks ago and while it has struggled ...
Streetwise Reports | September 6, 2019 |

Silver's Sharp Reaction Back

Technical analyst Clive Maund charts silver and explains why he believes it hasn't hit a final top. Silver reacted back sharply on Thursday and Friday after a parabolic blowoff top. This was not a final top, but it does indicate that silver needs to take a rest and co...
Streetwise Reports | September 10, 2019 |

T2 Biosystems Receives BARDA Contract to Fight Antimicrobial Resistance, Shares Up More than 88%

This healthcare diagnostics stock rose more than 88% on Wednesday following the award of a BARDA contract that could be worth up to $69 million. On Wednesday morning, T2 BioSystems Inc. (TTOO:NASDAQ) announced receipt of funding from the U.S. Department of Health a...
Streetwise Reports | September 12, 2019 |

PhaseBio Shares Are on a Tear After Reporting Phase 2a Trial Results

The clinical-stage biopharmaceutical stock surged more than 30% Wednesday following a report that PB2452 caused immediate and sustained reversal of ticagrelor in older and elderly subjects. In a press release issued September 24, PhaseBio Pharmaceuticals Inc. (PHAS...
Streetwise Reports | September 26, 2019 |

Assembly Biosciences Stock Sizzles Following Phase 2a Announcement and Buy Rating from Mizuho

Good news is piling up for this healthcare stock engaged in the treatment of hepatitis B as it trades at 5X its average volume with a 30% stock price gain over previous close. Assembly Biosciences Inc (ASMB:NASDAQ) announced in a press release on October 16, 2019, ...
Streetwise Reports | October 17, 2019 |

Oil & Gas Company Increases Credit Term Facility to Fund Second Well

The terms and the reason are presented in a Mackie Research Capital Corp. report. In a Nov. 1 research note, Mackie Research Capital Corp. analyst Bill Newman reported that Touchstone Exploration Inc. (TXP:TSX; PBEGF:OTC.MKTS) increased its term credit facility to $...
Streetwise Reports | November 14, 2019 |
1 2 3 4 5 6 7 8 9 10 ...